Sorin's CRM (cardiac rhythm management) president takes on role of CEO after prolonged absence at helm
This article was originally published in Clinica
Italian cardiovascular device manufacturer Sorin ended its four-month search for a new CEO last week when it officially appointed the president of its cardiac rhythm management (CRM) division Andre-Michel Ballaster to the executive role.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.